Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN. - Wikidata - wikimedia - TriplyDB

Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.

Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.

http://www.wikidata.org/entity/Q33688897

about

Prognostic value of the expression of phosphatase and tensin homolog and CD44 in elderly patients with refractory acute myeloid leukemia Influence of non-steroidal anti-inflammatory drugs on Drosophila melanogaster longevity MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma.COX-2 Promotes Migration and Invasion by the Side Population of Cancer Stem Cell-Like Hepatocellular Carcinoma Cells Metabolic enzymes: key modulators of functionality in cancer stem-like cells.Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.Blocking autophagy enhances meloxicam lethality to hepatocellular carcinoma by promotion of endoplasmic reticulum stress.Clinicopathological and prognostic significance of cyclooxygenase-2 expression in head and neck cancer: A meta-analysis.Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice.Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial.Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis.Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats.

P2860

Q35803001-DB72572C-AF4A-4886-92C4-EB833D5F52FF Q36260546-10296A16-A812-4FAD-91E7-6801439DE6CE Q36729381-44A7E10B-C0E5-4F4D-80F0-E64C39D77363 Q37026129-A92D5737-C0A2-4E3B-9C01-6A6C5262FD69 Q37706766-5D078E5B-D0CE-4B92-9684-1CE64761DA58 Q38686609-EBA45CFD-9727-41F7-9011-F3E4C0269C71 Q38826752-A98688C4-1353-4D4A-BA69-6068457600B7 Q39669567-7A288857-15BF-4423-820A-673430ADE207 Q41565207-A920AB2F-8AB2-4D30-9F19-D569B3888533 Q47144193-1A18BBF4-5E2B-43F0-A973-7E46B8F19451 Q51075784-731C03FF-267C-447C-9084-98F1B7A90312 Q52717528-77ABC770-76A2-4BB3-AAAD-AEE362266F4E

P2860

Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.

http://www.wikidata.org/entity/Q33688897

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.

@ast

Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.

@en

type

label

Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.

@ast

Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.

@en

prefLabel

Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.

@ast

Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.

@en

P1433

Q33688897-09DE7647-0043-4132-8947-74D61B5E2D5E

P1476

Q33688897-0C61A5E5-B1E1-4B5F-949D-E304B7CBD5BC

P2093

Q33688897-06972D9F-A928-4D72-94B5-D31C2B794B86

Q33688897-1153992D-2994-4F40-9594-A86A6F9F3066

Q33688897-2E2D334F-EAE0-473D-BC0B-A4440D50D2A9

Q33688897-32968611-9441-43DE-95AB-EE40C384B1CF

Q33688897-4C4705E7-A109-44DA-8446-4278DD42847A

Q33688897-5745CDA1-E14E-4600-BD59-4E8CC453D1A6

Q33688897-6921AF8C-C13A-40AD-96CC-92CD919D2616

Q33688897-7AE73BB6-536C-4BF6-9A92-03EB6D064CA5

Q33688897-7F99CFFE-EA66-4C30-A177-F1D516567B6B

Q33688897-816F15CE-3CE4-463D-B0C1-B73735DAC1AD

P2860

Q33688897-078139CC-D908-4E90-8621-AF2907B3B6A7

Q33688897-07C6F768-32EC-4CB7-AFF0-56D63DBFD2D7

Q33688897-0CBBAA78-D47D-44FD-A20F-019B42D01384

Q33688897-139B7DE4-1E4E-4D52-BCA9-270CDA95934E

Q33688897-141C067B-C686-4038-8FCE-FCA630ABC11A

Q33688897-1B01095E-9D3C-4243-B614-51EE3ACD9EF6

Q33688897-1BA29BC8-3587-4194-8AE7-161A99DAECCC

Q33688897-1C614529-543A-47F7-A953-14DD4E6865E3

Q33688897-23108FD7-475D-467F-B69F-A520079B5E18

Q33688897-23B79BE3-CF21-4E96-81A7-42FE8C7B478A

P304

Q33688897-4223A754-437B-4C8B-82CF-82447186B348

P31

Q33688897-27A594E1-FA51-4A9B-B42E-A20D48118593

P356

Q33688897-3949F9A0-AA02-465A-9708-AF2A3A10F2E4

P407

Q33688897-052FB7E6-2788-43E4-BEBF-C72019EC7D87

P433

Q33688897-9BCFBE25-981B-44BD-8E2B-95ADDAE2FE9B

P478

Q33688897-0CECA79C-7A82-45B7-9B88-3B7EA512A6BF

P577

Q33688897-7D1CB4ED-69E0-49A1-8BB5-7C4BD13A3D45

P5875

Q33688897-B64D8153-2AC0-4836-8DC7-35082B3A98D4

P698

Q33688897-79B2F69C-FA76-4720-B82F-6372FF9B7A70

P932

Q33688897-113F0F06-0A9A-4401-A71F-E0B863403809

P356

ONCOTARGET.1745

P1433

P1476

Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.

@en

P2093

Cheuk-Kwan Sun

http://www.w3.org/2001/XMLSchema#string

E-Ming Wang

http://www.w3.org/2001/XMLSchema#string

Hoi-Hung Chan

http://www.w3.org/2001/XMLSchema#string

Hsiao-Mei Kuo

http://www.w3.org/2001/XMLSchema#string

Kwan-Hung Cheng

http://www.w3.org/2001/XMLSchema#string

Kwok Hung Lai

http://www.w3.org/2001/XMLSchema#string

Li-Fen Liu

http://www.w3.org/2001/XMLSchema#string

Mei-Lang Kung

http://www.w3.org/2001/XMLSchema#string

Ming-Hong Tai

http://www.w3.org/2001/XMLSchema#string

Ping-I Hsu

http://www.w3.org/2001/XMLSchema#string

P2860

Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis

The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

Stem cells, cancer, and cancer stem cells

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration

Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation.

Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling.

Functional heterogeneity of breast fibroblasts is defined by a prostaglandin secretory phenotype that promotes expansion of cancer-stem like cells.

Glioblastoma stem-like cells give rise to tumour endothelium.

P304

1475-1490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.1745

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261603431

http://www.w3.org/2001/XMLSchema#string

P698

24721996

http://www.w3.org/2001/XMLSchema#string

P932

4039225

http://www.w3.org/2001/XMLSchema#string